The novel finding that relaxin has an action on the brain was first published in 1984. Since then, it has been shown that exogenous relaxin affects the release of a number of hypothalamo-pituitary hormones and has a robust pressor action. In this paper, we review the accumulating evidence that relaxin affects the release of oxytocin and vasopressin by an action at the level of the brain. The potential mechanisms of this central action are discussed and the evidence presented for the interaction between relaxin and the forebrain angiotensin-ll system. Furthermore, we articulate the possible physiological influences of relaxin on the changes in cardiovascular function that occur during pregnancy.F. L. Hisaw ( I ) discovered an ovarian substance that caused relaxation of the pelvic ligament of a variety of species in 1926 but it was not until 1930 that the first crude extract of the substance was obtained and named relaxin (2). Initial work focused on the role of relaxin on the birth canal and it was not until 1957 that an effect on the cardiovascular system was first reported (3). Miller and colleagues (3) showed that an extract of ovary caused a short hypotensive episode in dogs and suggested that relaxin had a direct action on peripheral blood vessels. Since that time. a number of hemodynamic actions of relaxin have been described (4, 5). The balance of the data, however, suggests that relaxin is hypertensive and exerts this effect through an action at the level of the brain (6-9) and on the heart (10, 11).
RelaxinRelaxin is a peptide hormone produced primarily by the corpus luteum, placenta, uterus and possibly brain. It is present in detectable quantities in the peripheral circulation only during pregnancy. There are considerable species differences in the site and pattern of release of the hormone, hormone structure, and the putative role the hormone plays in the preparturient period. These differences have been extensively reviewed by Sherwood (4). Most research into the physiological actions of relaxin has been carried out using porcine relaxin obtained by the method described by Sherwood and O'Byrne (12). The classic actions of relaxin in pregnancy include softening of the cervix (13), separation of the pelvic symphysis (14). and maintenance of myornetrial quiescence towards the end of pregnancy ( 15).In the rat, relaxin is produced almost entirely within the corpora lutea of pregnancy (16) although there is some evidence that the hormone may also be produced by the endometrium (17). Levels of hormone are below the limit of detectability, by radioimmunoassay. during the first 7/12 days of pregnancy and start to increase from day 7 onwards. The levels increase steadily until day 16 when they begin to plateau. In the 48 h before birth, in association with the collapse of the corpora lutea, relaxin levels show a sharp peak then fall to low levels before birth starts (18). Sherwood et al. (18) also reported that there were peaks of relaxin in parturition. Although these data have not been confirmed by ...